Listar por autor "Skoularingis, I."
Mostrando ítems 1-4 de 4
-
Effect of Ranolazine in Preventing Postoperative Atrial Fibrillation in Patients Undergoing Coronary Revascularization Surgery
Tagarakis, G. I.; Aidonidis, I.; Daskalopoulou, S. S.; Simopoulos, V.; Liouras, V.; Daskalopoulos, M. E.; Parisis, C.; Papageorgiou, K.; Skoularingis, I.; Triposkiadis, F.; Molyvdas, P. A.; Tsilimingas, N. B. (2013)Background/Objective: Ranolazine is a new anti-ischemic agent approved for chronic angina with additional electrophysiologic properties. The purpose of the present trial was to investigate its effect in preventing postoperative ... -
Impact of ranolazine in preventing postoperative atrial fibrillation in patients after on-pump coronary artery bypass graft surgery
Tagarakis, G.; Aidonidis, I.; Liouras, V.; Papageorgiou, K.; Parissis, C.; Skoularingis, I.; Molyvdas, P. A.; Tsilimingas, N. (2012) -
Ranolazine enhances the antiarrhythmic activity of amiodarone by accelerating conversion of new-onset atrial fibrillation after cardiac surgery
Aidonidis, I.; Simopoulos, V.; Tagarakis, G.; Skoularingis, I.; Leftheriotis, D.; Rizos, I.; Molyvdas, P. A.; Tsilimingas, N. (2013) -
Ranolazine Enhances the Antiarrhythmic Activity of Amiodarone by Accelerating Conversion of New-Onset Atrial Fibrillation After Cardiac Surgery
Simopoulos, V.; Tagarakis, G. I.; Daskalopoulou, S. S.; Daskalopoulos, M. E.; Lenos, A.; Chryssagis, K.; Skoularingis, I.; Molyvdas, P. A.; Tsilimingas, N. B.; Aidonidis, I. (2014)Ranolazine is a relatively novel antiischemic/antianginal compound with antiarrhythmic properties. We investigated its ability to shorten the time to conversion of postoperative atrial fibrillation (POAF) when added to ...